References

Biomarkers of liver cell death

10.1016/j.jhep.2013.12.026 · 2014 · External reference

Keratin 8/18 breakdown and reorganization during apoptosis

10.1016/j.yexcr.2004.02.019 · 2004 · External reference

Cell death markers in patients with cirrhosis and acute decompensation

10.1002/hep.29581 · 2018 · External reference

Clinical significance of serum Ck18-M65 and M30 levels in patients with chronic hepatitis B combined with nonalcoholic steatohepatitis and liver fibrosis

10.1097/md.0000000000038342 · 2024 · External reference

PD-L1(+) neutrophils induced NETs in malignant ascites is a potential biomarker in HCC

10.1007/s00262-024-03833-z · 2024 · External reference

Risks and benefits of TIPS in HCC and other liver malignancies: a literature review

10.1186/s12876-023-03047-0 · 2023 · External reference

Keratins: biomarkers and modulators of apoptotic and necrotic cell death in the liver

10.1002/hep.28493 · 2016 · External reference

Serum level of cytokeratin 18 (M65) as a prognostic marker of high cardiovascular disease risk in individuals with non-alcoholic fatty liver disease

10.3390/biom13071128 · 2023 · External reference

Poor inter-test reliability between CK18 kits as a biomarker of NASH

10.1007/s10620-015-3916-1 · 2016 · External reference

The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry

10.1016/j.jim.2009.06.003 · 2009 · External reference

Development of an SI-traceable magnetic solid-phase extraction coupled with isotope dilution LC-MS/MS method for accurate quantification of alpha-fetoprotein in human serum

10.1016/j.talanta.2025.128606 · 2026 · External reference

Protein biomarker quantification by immunoaffinity liquid chromatography-tandem mass spectrometry: current state and future vision

10.1093/clinchem/hvz022 · 2020 · External reference

An optimized UPLC-MS/MS method for human plasma amyloid-β 42 and 40 measurement and application in Alzheimer’s disease diagnosis

10.1016/j.jpba.2024.116396 · 2024 · External reference

Development of a high-throughput liquid chromatography-tandem mass spectrometry platform for the determination of intact natriuretic peptides in human plasma

10.1016/j.talanta.2024.126077 · 2024 · External reference

Absolute protein quantification by mass spectrometry: not as simple as advertised

10.1021/acs.analchem.7b00858 · 2017 · External reference

Quantification of the lung cancer tumor marker CYFRA 21-1 using protein precipitation, immunoaffinity bottom-up LC-MS/MS

10.1515/cclm-2023-0795 · 2024 · External reference

Sample preparation strategies for targeted proteomics via proteotypic peptides in human blood using liquid chromatography tandem mass spectrometry

10.1002/prca.201400121 · 2015 · External reference

A multiplexed cytokeratin analysis using targeted mass spectrometry reveals specific profiles in cancer-related pleural effusions

10.1016/j.neo.2016.06.002 · 2016 · External reference

Unresolved reference

2014 · External reference

Unresolved reference

2014 · External reference

Improved methods for separation of human cytokeratins

10.1016/0024-3205(90)90576-d · 1990 · External reference

FIB-4 and APRI for cirrhosis detection in a privately insured national cohort

2024 · External reference

Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells

10.1158/1078-0432.ccr-05-0632 · 2005 · External reference

Recent developments in mass-spectrometry-based targeted proteomics of clinical cancer biomarkers

10.1186/s12014-024-09452-1 · 2024 · External reference

Automated proteomic sample preparation: the key component for high throughput and quantitative mass spectrometry analysis

10.1002/mas.21750 · 2023 · External reference

Enzyme-friendly, mass spectrometry-compatible surfactant for in-solution enzymatic digestion of proteins

10.1021/ac0346196 · 2003 · External reference

Highly reproducible automated proteomics sample preparation workflow for quantitative mass spectrometry

10.1021/acs.jproteome.7b00623 · 2018 · External reference

Blood metabolic panels for identifying significant fibrosis and inflammation in patients with MASLD

2026 · External reference

Cytokeratin 18-based cell death markers indicate severity of liver disease and prognosis of cirrhotic patients

10.1111/liv.13117 · 2016 · External reference

Ascitic fluid analysis in the differential diagnosis of ascites: focus on cirrhotic ascites

2014 · External reference